Article Information
History
- June 5, 2020.
Article Versions
- Version 1 (January 10, 2020 - 03:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Penny J. Norsworthy1,
- Andrew G.B. Thompson2,
- Tze H. Mok2,
- Fernando Guntoro1,
- Luke C. Dabin1,
- Akin Nihat2,
- Ross W. Paterson3,
- Jonathan M. Schott3,
- John Collinge1,2,
- Simon Mead1,2,* and
- Emmanuelle A. Viré1
- 1MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, UK
- 2National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK
- 3Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK
- ↵*Corresponding author: Prof. Simon Mead, MRC Prion Unit at UCL, UCL Institute of Prion Diseases, Courtauld Building, 33 Cleveland Street, London, W1W 7FF, UK. Email: s.mead{at}prion.ucl.ac.uk, Tel: +44 20 7679 5152
Posted June 05, 2020.
A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis
